InsidersTradesSigma
Discover the detailed record of transactions filed by Ende Eric J, Director. Insider active across 2 companies, notably Matinas BioPharma Holdings, Inc.. Cumulatively, 4 reports have been recorded. Total volume traded: €64k. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Eric J. Ende is a Board Member at Matinas BioPharma Holdings, Inc. and AVADEL PHARMACEUTICALS PLC. He contributes to the company's strategy and important decision-making. His experience in the pharmaceutical sector is an asset for the company's future direction.